PharmaResearch Co., Ltd. (KOSDAQ:214450)
401,500
-9,500 (-2.31%)
At close: Dec 5, 2025
PharmaResearch Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,171,444 | 2,727,283 | 1,116,952 | 697,316 | 818,025 | 552,155 | Upgrade
|
| Market Cap Growth | 83.33% | 144.17% | 60.18% | -14.76% | 48.15% | 60.62% | Upgrade
|
| Enterprise Value | 3,872,029 | 2,575,782 | 990,868 | 612,568 | 761,136 | 536,011 | Upgrade
|
| Last Close Price | 401500.00 | 262500.00 | 109041.14 | 68996.50 | 80178.04 | 55527.18 | Upgrade
|
| PE Ratio | 27.64 | 29.63 | 14.59 | 17.18 | 17.52 | 16.85 | Upgrade
|
| Forward PE | 18.76 | 22.06 | 12.55 | 10.92 | 14.49 | 15.04 | Upgrade
|
| PS Ratio | 8.41 | 7.79 | 4.28 | 3.58 | 5.31 | 5.08 | Upgrade
|
| PB Ratio | 6.05 | 4.78 | 2.42 | 1.88 | 2.49 | 2.09 | Upgrade
|
| P/TBV Ratio | 6.64 | 5.38 | 2.77 | 2.27 | 3.10 | 2.67 | Upgrade
|
| P/FCF Ratio | 33.16 | 26.82 | 21.12 | 16.55 | 18.32 | - | Upgrade
|
| P/OCF Ratio | 25.89 | 19.75 | 17.20 | 11.74 | 12.53 | 17.05 | Upgrade
|
| EV/Sales Ratio | 7.81 | 7.36 | 3.80 | 3.15 | 4.94 | 4.93 | Upgrade
|
| EV/EBITDA Ratio | 18.27 | 18.44 | 9.50 | 8.01 | 12.27 | 12.83 | Upgrade
|
| EV/EBIT Ratio | 19.74 | 20.43 | 10.74 | 9.29 | 14.50 | 16.04 | Upgrade
|
| EV/FCF Ratio | 30.78 | 25.33 | 18.74 | 14.53 | 17.05 | - | Upgrade
|
| Debt / Equity Ratio | 0.31 | 0.37 | 0.07 | 0.18 | 0.20 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 1.00 | 1.49 | 0.33 | 0.87 | 1.06 | 0.78 | Upgrade
|
| Debt / FCF Ratio | 1.68 | 2.05 | 0.65 | 1.58 | 1.47 | - | Upgrade
|
| Asset Turnover | 0.61 | 0.50 | 0.52 | 0.43 | 0.41 | 0.37 | Upgrade
|
| Inventory Turnover | 1.91 | 1.84 | 1.90 | 2.55 | 2.40 | 2.07 | Upgrade
|
| Quick Ratio | 6.55 | 5.84 | 2.96 | 4.04 | 3.86 | 2.87 | Upgrade
|
| Current Ratio | 7.57 | 6.75 | 3.89 | 4.56 | 4.31 | 3.55 | Upgrade
|
| Return on Equity (ROE) | 23.58% | 17.23% | 18.53% | 12.41% | 15.80% | 13.17% | Upgrade
|
| Return on Assets (ROA) | 15.05% | 11.33% | 11.38% | 9.10% | 8.78% | 7.08% | Upgrade
|
| Return on Capital (ROIC) | 16.62% | 12.35% | 12.34% | 9.90% | 9.50% | 7.65% | Upgrade
|
| Return on Capital Employed (ROCE) | 21.90% | 16.30% | 19.70% | 15.60% | 13.80% | 11.80% | Upgrade
|
| Earnings Yield | 3.63% | 3.38% | 6.85% | 5.82% | 5.71% | 5.94% | Upgrade
|
| FCF Yield | 3.02% | 3.73% | 4.74% | 6.04% | 5.46% | -0.43% | Upgrade
|
| Dividend Yield | 0.27% | 0.42% | 0.87% | 0.96% | 0.75% | 0.90% | Upgrade
|
| Payout Ratio | 7.94% | 10.96% | 9.84% | 15.56% | 10.77% | 9.04% | Upgrade
|
| Buyback Yield / Dilution | 6.08% | 2.50% | -5.85% | 0.76% | -5.74% | -0.73% | Upgrade
|
| Total Shareholder Return | 6.35% | 2.92% | -4.97% | 1.72% | -4.99% | 0.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.